Table 3 PDE inhibition and selectivity

From: Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

Drug

Geometric mean IC50 values (μM) [fold selectivity versus PDE5 in parentheses]

 

PDE1

PDE2

PDE3

PDE4

PDE5

PDE6 (rod)

PDE6 (cone)

PDE7A

PDE8A

PDE9A

PDE10A

PDE11A

Sildenafil

0.281 [80]

>30 [>8,570]

16.2 [4,630]

7.68 [2,190]

0.00350

0.037 [11]

0.034 [10]

21.3 [6,090]

29.8 [8,510]

2.61 [750]

9.80 [2,800]

2.73 [780]

Tadalafil

>30 [>4,450]

>100 [>14,800]

>100 [>14,800]

>100 [>14,800]

0.00674

1.26 [187]

1.30 [193]

>100 [>14,800]

>100 [>14,800]

>100 [>14,800]

>100 [>14,800]

0.037 [5]

Vardenafil

0.070 [500]

6.20 [44,290]

>1.0 [>7,140]

6.10 [43,570]

0.00014

0.0035 [25]

0.0006 [4]

>30 [>214,000]

>30 [>214,000]

0.581 [4,150]

3.0 [21,200]

0.162 [1,160]

IC50 values were determined using either native enzyme purified from human tissue (PDE1, heart; PDEs 2, 3 and 5, corpus cavernosum; PDE4, skeletal muscle; PDE6, retina) or using recombinant human enzymes expressed in Sf9 cells (PDEs 7?11) and purified by anion-exchange chromatography. Adapted from Ref. 29. IC50, drug concentration necessary to inhibit 50% of enzyme activity; PDE, phosphodiesterase.